Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹-61 Cr₹25 Cr₹61 Cr₹101 Cr₹135 Cr

What is the latest Total Non-Current Liabilities ratio of NATCO PHARMA ?

The latest Total Non-Current Liabilities ratio of NATCO PHARMA is ₹-61 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹-61 Cr
Mar2025₹25 Cr
Mar2024₹61 Cr
Mar2023₹101 Cr
Mar2022₹135 Cr

How is Total Non-Current Liabilities of NATCO PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹-61 Cr
Negative
Mar2025 ₹25 Cr
-59.18
Mar2024 ₹61 Cr
-39.30
Mar2023 ₹101 Cr
-25.61
Mar2022 ₹135 Cr -

Compare Total Non-Current Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,045.3 Cr 3.4% -2.8% -5.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr 1% -3.3% 13.1% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 2.6% 10.8% 57.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 2.7% 0.3% 39.6% Stock Analytics
CIPLA ₹112,876.0 Cr 2.4% -1.1% -12.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 2.5% 0.8% -8.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

3.4%

-2.8%

-5.3%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses